CMI
56
5
IVZ
53
5
NTRS
54
7
PM
50
-2
PVH
54
2
JPM
55
2
AES
49
-2
GRMN
52
2
A
46
3
AMT
55
-3
IR
77
8
SHW
73
2
DG
14
2
LUV
33
-3
MUR
52
3
IPG
42
3
EXC
47
-3
ADM
36
6
ABBV
53
2
CMG
54
4
CMI
56
5
IVZ
53
5
NTRS
54
7
PM
50
-2
PVH
54
2
JPM
55
2
AES
49
-2
GRMN
52
2
A
46
3
AMT
55
-3
IR
77
8
SHW
73
2
DG
14
2
LUV
33
-3
MUR
52
3
IPG
42
3
EXC
47
-3
ADM
36
6
ABBV
53
2
CMG
54
4
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

UTHR
United Therapeutics

Last Price:
352.27
Seasonality Move:
2.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

United Therapeutics Price Quote

$352.27
+0.94 (+0.27%)
(Updated: September 20, 2024 at 10:30 AM ET)

United Therapeutics Key Stats

Buy
55
United Therapeutics (UTHR) is a Buy
Day range:
$344.47 - $353.04
52-week range:
$208.62 - $366.08
Dividend yield:
0%
P/E ratio:
17.74
P/S ratio:
6.61
P/B ratio:
2.74%
Volume:
431.5K
Avg. volume:
446.8K
1-year change:
59.21%
Market cap:
$15.6B
Revenue:
$2.3B
EPS:
$21.76

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.2%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.12%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.2B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $384M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 16.95%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 15.69%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

United Therapeutics Dividend Yield

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 11.64% 0%
Revenue: 19.85% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 350.71
Downside from Last Price: -0.18%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    80.6M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    120.6K UTHR shares are owned by insiders